New Health Technology Assessment (nHTA) Committee recognizes confocal laser endomicroscopy as “safe and effective technology in application...
Mauna Kea Technologies announced the appointment of Molly O’Neill to the Company’s Board of Directors, effective immediately. She...
Pivotal regulatory milestone positioning Cellvizio as unique real-time in vivo visualization system Cellvizio platform complementary to a wide range...
Please download the official press release for full details
Croatian Health Insurance Fund Now Provides Reimbursement for Cellvizio® advanced endomicroscopy technology for patients affected by...
New CONTACT Study Outcomes Presented today in Late-Breaking Session at United European Gastroenterology Week (UEGW) 2017 Mauna Kea Technologies...
Mauna Kea Technologies announced the appointment of Olivier Regnard to the position of Deputy Chief Executive Officer and Chief Financial...
Study shows a 23% reduction in surgical interventions resulting in 14% reduction in clinical costs Mauna Kea Technologies today announced the...
Mauna Kea Technologies passes another key regulatory milestone on its ambitious product roadmap, positioning Cellvizio as a key technology to...
Click to read more
Results reflect strategic focus on transition to Cellvizio pay-per-use business model in the U.S. Mauna Kea Technologies will host a conference call...
Cook Urology to market private-labeled version of Cellvizio globally Paris and Boston, September 05, 2017 – Mauna Kea Technologies (Euronext:...
